Onyx Bio

Onyx Bio

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.onyx.bio/

Last Round

Seed Round

Feb 26, 2026

Total Funding Raised

$10M

Momentum Score

75 /100

Company Overview

Onyx Bio is a biotechnology company building a virtual immune system for faster and safer development of precision medicines by integrating multiomics data with longitudinal patient records.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Drug Discovery, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Data as a Service, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

precision medicinemultiomics datadrug discoveryautoimmune disease researchlongitudinal datareal-world dataRWDbioinformatics platformbiological data platformclinical data platformAI data analysisbiorepository managementreal-world evidenceRWEData as a ServiceDaaSdata equity

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Onyx Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Onyx Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Seed RoundFeb 26, 2026
SeedMar 12, 2025

Key People

Founding team and executive leadership

Amit Lakhani

Co-Founder CTO

Founding Team

Roger Chen

Cofounder CEO

Founding Team

Onyx Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    Monthly visitors increased 64% MoM to 31.1K.

Onyx Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Onyx Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Onyx Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range7
Year FoundedN/A
Last FundingFeb 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.